[1]
T. Satnarine, “Immunotherapy for Post-COVID Neuropsychiatric Symptoms: The Potential of IVIG Treatment”, jmhs, vol. 4, no. 2, pp. 79–85, Apr. 2023, doi: 10.32996/jmhs.2023.4.2.11.